Home > Healthcare > Medical Devices > Medical Supplies > Urometer Market

Urometer Market Share

Report ID: GMI11766
Published Date: Oct 2024
Report Format: PDF

Download Free Sample

Urometer Market Share

The market characterized by a blend of established medical device manufacturers and emerging players focused on innovating urine monitoring solutions. Key players offer advanced urometers that incorporate digital technology for accurate, real-time data tracking. They emphasize product development, strategic partnerships, and mergers to strengthen their market presence. The rising trend towards infection control and the demand for disposable urometers are increasing competition among manufacturers to provide safe, user-friendly, and cost-effective products. As healthcare providers prioritize patient safety and quality care, companies are heavily investing in research and development to address the evolving needs of the sector, further intensifying market competition.

Urometer Market Companies

Prominent players operating in the urometer industry include:

Advin Health Care
Angiplast Private Limited
B. Braun Melsungen AG
Becton, Dickinson and Company
Cardinal Health, Inc.
Convatec Inc.
Fannin
Forlong Medical Co.,Ltd.
Hitec Medical Co., Ltd.
Laborie
Medline Industries, LP
Observe Medical ASA
Romsons Group
Sterimed Group
Teleflex Incorporated

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The industry was valued at USD 512.4 million in 2023 and is expected to grow at a CAGR of 7.2% from 2024 to 2032. This growth is driven by advancements in technology, increasing kidney and urinary disorders, an aging population, and more surgeries and ICU admissions.

The disposable segment dominated the market in 2023 with an 82.3% share. The rise in chronic conditions like kidney disease, diabetes, and heart failure necessitates consistent urine output monitoring.

In 2023, the North American market recorded USD 202.4 million in revenue and is projected to grow at a CAGR of 6.7% from 2024 to 2032. The increasing prevalence of chronic diseases such as diabetes, kidney disease, and cardiovascular disorders drives this demand.

Key players include Advin Health Care, Angiplast Private Limited, B. Braun Melsungen AG, Becton, Dickinson and Company, Cardinal Health, Inc., Convatec Inc., Fannin, Forlong Medical Co., Ltd., Hitec Medical Co., Ltd., and Laborie.